Dakota Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
4,901
-3,069
| -39% | -$197K | 0.01% | 602 |
|
|
2025
Q1 | $506K | Sell |
7,970
-1,100
| -12% | -$69.8K | 0.01% | 503 |
|
|
2024
Q4 | $603K | Sell |
9,070
-200
| -2% | -$13.3K | 0.01% | 469 |
|
|
2024
Q3 | $647K | Sell |
9,270
-1,200
| -11% | -$83.8K | 0.01% | 457 |
|
|
2024
Q2 | $679K | Hold |
10,470
| – | – | 0.02% | 446 |
|
|
2024
Q1 | $678K | Hold |
10,470
| – | – | 0.02% | 447 |
|
|
2023
Q4 | $689K | Sell |
10,470
-1,810
| -15% | -$119K | 0.03% | 373 |
|
|
2023
Q3 | $700K | Buy |
12,280
+250
| +2% | +$14.3K | 0.03% | 340 |
|
|
2023
Q2 | $737K | Sell |
12,030
-600
| -5% | -$36.8K | 0.03% | 303 |
|
|
2023
Q1 | $793K | Sell |
12,630
-250
| -2% | -$15.7K | 0.05% | 269 |
|
|
2022
Q4 | $818K | Hold |
12,880
| – | – | 0.06% | 251 |
|
|
2022
Q3 | $759K | Buy |
+12,880
| New | +$759K | 0.06% | 252 |
|